INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 319 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,311 | -29.4% | 2,192 | -8.9% | 0.04% | -27.6% |
| Q2 2023 | $98,117 | +0.9% | 2,406 | -7.8% | 0.06% | +7.4% |
| Q1 2023 | $97,275 | -22.8% | 2,610 | -27.7% | 0.05% | -18.2% |
| Q4 2022 | $125,953 | -17.1% | 3,610 | +32.7% | 0.07% | +8.2% |
| Q3 2022 | $152,000 | +9.4% | 2,720 | +1.0% | 0.06% | +17.3% |
| Q2 2022 | $139,000 | +41.8% | 2,694 | +99.1% | 0.05% | +18.2% |
| Q1 2022 | $98,000 | -41.7% | 1,353 | -5.1% | 0.04% | -30.2% |
| Q4 2021 | $168,000 | -48.3% | 1,425 | -41.1% | 0.06% | -55.9% |
| Q3 2021 | $325,000 | -21.1% | 2,419 | -4.8% | 0.14% | -15.4% |
| Q2 2021 | $412,000 | -10.8% | 2,542 | -55.9% | 0.17% | -13.3% |
| Q1 2021 | $462,000 | +50.0% | 5,761 | +1.7% | 0.20% | +52.3% |
| Q4 2020 | $308,000 | -2.8% | 5,662 | -64.5% | 0.13% | -22.9% |
| Q3 2020 | $317,000 | -16.6% | 15,927 | -12.0% | 0.17% | -7.8% |
| Q2 2020 | $380,000 | – | 18,100 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |